A research team at the Icahn School of Medicine has developed a new artificial intelligence (AI) platform to identify different neurodegenerative disorders using brain tissue samples.
The team combined advanced computer science and mathematical approaches with microscope technology, computer vision and AI to more accurately classify a variety of disorders.
Called the Precise Informatics Platform, this new solution is expected to facilitate targeted biomarkers and therapeutics for better diagnosis and outcomes in patients with complex brain conditions.
